home / stock / hils / hils news

HILS News and Press, Hillstream BioPharma Inc. From 05/02/23

Stock Information
Company Name: Hillstream BioPharma Inc.
Stock Symbol: HILS
Market: NASDAQ
Menu
HILS HILS Quote HILS Short HILS News HILS Articles HILS Message Board
Get HILS Alerts

News, Short Squeeze, Breakout and More Instantly...
HILS - Hillstream BioPharma Announces Closing of Public Offering of Common Stock

BRIDGEWATER, N.J., May 02, 2023 (GLOBE NEWSWIRE) --  Hillstream BioPharma, Inc. (Nasdaq: HILS) ("Hillstream" or the "Company"), a biotechnology company developing therapeutic candidates targeting drug resistant and devastating cancers using ferroptosis, an emerging new anti-cancer mechanism ...
HILS - Hillstream BioPharma to Present at Upcoming May 2023 Investor and Industry Conferences

12th Drug Discovery Strategic Summit, being held May 3-4 in Boston, MA Sidoti Micro-Cap Virtual Conference, being held virtually on May 10-11 World Orphan Drug Congress, being held May 23-25 in Washington, D.C. BRIDGEWATER, N.J., May 02, 2023 (GLOBE NEWSWIRE) -- Hillstream...

HILS - Tempest, CVRx top healthcare gainers; Hillstream, Addus among losers

2023-04-28 10:03:38 ET Gainers: Tempest Therapeutics ( TPST ) +72% . CVRx ( CVRX ) +25% . ImmunoGen ( IMGN ) +22% . Apyx Medical ( APYX ) +17% . bluebird bio ( BLUE ) +17% . Losers: Hillstream BioPharma ( HILS ) -56%...

HILS - PBR, SGMO and EHTH among pre-market losers

2023-04-28 08:33:44 ET Hillstream BioPharma ( HILS ) -57% on pricing $2.65M equity offering . Centogene ( CNTG ) -26% receives Nasdaq non-compliance notice . Cloudflare ( NET ) -25% after Q1 earnings release . Snap ( SNAP ) -18% afte...
HILS - Hillstream BioPharma sheds 53% on pricing $2.65M equity offering

2023-04-28 04:17:28 ET Hillstream BioPharma ( NASDAQ: HILS ) is down 53.11% premarket after the firm has priced its underwritten public offering of 5.3M shares of its common stock. Each share is being sold to the public at a price of $0.50 for gross pro...

HILS - Hillstream BioPharma Announces Pricing of Public Offering

BRIDGEWATER, N.J., April 27, 2023 (GLOBE NEWSWIRE) -- Hillstream BioPharma, Inc. (Nasdaq: HILS) ("Hillstream" or the "Company"), a biotechnology company developing therapeutic candidates targeting drug resistant and devastating cancers using ferroptosis, an emerging new anti-cancer mechanism resu...

HILS - Hillstream BioPharma proposes stock and warrants offering, shares fall 20%

2023-04-27 16:18:17 ET Hillstream BioPharma ( NASDAQ: HILS ) said Thursday it intends to offer shares of its common stock, and/or pre-funded warrants in an underwritten public offering. All of the shares of common stock and/or pre-funded warrants are to be sold by H...
HILS - Hillstream BioPharma Announces Proposed Public Offering

BRIDGEWATER, N.J., April 27, 2023 (GLOBE NEWSWIRE) -- Hillstream BioPharma, Inc. (Nasdaq: HILS) ("Hillstream" or the "Company"), a biotechnology company developing therapeutic candidates targeting drug resistant and devastating cancers using ferroptosis, an emerging new anti-cancer mechanism resu...

HILS - Ocean Biomedical, ContraFect top healthcare gainers; GlucoTrack, ViewRay among losers

2023-04-13 10:02:55 ET Gainers: Ocean Biomedical ( OCEA ) +24% . ContraFect ( CFRX ) +21% . bluebird bio ( BLUE ) +18% . Evaxion Biotech ( EVAX ) +17% . Hillstream BioPharma ( HILS ) +10% . Losers: GlucoTrack ( GCTK ) ...

HILS - Hillstream BioPharma Selects OncoBay Clinical to Advance Clinical and Regulatory Development for its Lead Drug Candidate HSB-1216, an Anti-Cancer Mechanism

BRIDGEWATER, N.J., April 13, 2023 (GLOBE NEWSWIRE) -- Hillstream BioPharma, Inc. (Nasdaq: HILS) ("Hillstream" or the "Company"), a biotechnology company developing therapeutic candidates targeting drug resistant and devastating cancers using ferroptosis, an emerging new anti-cancer mechanism resu...
Previous 10 Next 10